Premium
The follow‐up of progressive hypertrophic cardiomyopathy using magnetic resonance rotating frame relaxation times
Author(s) -
Khan Muhammad Arsalan,
Laakso Hanne,
Laidinen Svetlana,
Kettunen Sanna,
Heikura Tommi,
YläHerttuala Seppo,
Liimatainen Timo
Publication year - 2018
Publication title -
nmr in biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 114
eISSN - 1099-1492
pISSN - 0952-3480
DOI - 10.1002/nbm.3871
Subject(s) - hypertrophic cardiomyopathy , magnetic resonance imaging , fibrosis , myocardial fibrosis , cardiomyopathy , masson's trichrome stain , muscle hypertrophy , medicine , relaxation (psychology) , cardiology , pathology , nuclear magnetic resonance , radiology , heart failure , physics
Magnetic resonance rotating frame relaxation times are an alternative non‐contrast agent choice for the diagnosis of chronic myocardial infarct. Fibrosis typically occurs in progressive hypertrophic cardiomyopathy. Fibrosis has been imaged in myocardial infarcted tissue using rotating frame relaxation times, which provides the possibility to follow up progressive cardiomyopathy without contrast agents. Mild and severe left ventricular hypertrophy were induced in mice by transverse aortic constriction, and the longitudinal rotating frame relaxation times ( T 1ρ ) and relaxation along the fictitious field ( T RAFF2 , T RAFF3 ) were measured at 5, 10, 24, 62 and 89 days after transverse aortic constriction in vivo . Myocardial fibrosis was verified using Masson's trichrome staining. Increases in the relative relaxation time differences of T 1ρ , together with T RAFF2 and T RAFF3 , between fibrotic and remote tissues over time were observed. Furthermore, T RAFF2 and T RAFF3 showed higher relaxation times overall in fibrotic tissue than T 1ρ . Relaxation time differences were highly correlated with an excess of histologically verified fibrosis. We found that T RAFF2 and T RAFF3 are more sensitive than T 1ρ to hypertrophic cardiomyopathy‐related tissue changes and can serve as non‐invasive diagnostic magnetic resonance imaging markers to follow up the mouse model of progressive hypertrophic cardiomyopathy.